牙周炎与年龄相关的黄斑退化之间的系统审查和元分析:个性化方法的潜力
Sophie Boberg-Ans1, Frederikke Arnold-Vangsted2, Anna Bonde Scheel-Bech3
1Nord Specialtandlæger, 2880 Kongens Lyngby, Denmark.
Journal of personalized medicine
|April 25, 2025
概括
牙周炎是一种牙疾病,与与年龄相关的黄斑变性 (AMD) 有着显著的联系. 治疗牙周炎可能有助于降低AMD风险,为眼睛健康提供可修改的因素.
科学领域:
- 眼科和牙周科的眼科.
- 系统性炎症研究 系统性炎症研究
背景情况:
- 牙周炎是一种慢性炎症状况,与全身低度炎症相关.
- 在被诊断患有与年龄相关的黄斑变性 (AMD) 的患者中也观察到系统性炎症.
研究的目的:
- 系统地审查和对现有文献进行元分析,以评估牙周炎和与年龄有关的黄斑变性 (AMD) 之间的关联.
主要方法:
- 对11个科学数据库进行了全面的搜索,寻找研究牙周炎和AMD的研究.
- 在重复审查和偏见风险评估后,包括了七项符合条件的研究,涉及149,217名参与者.
- 进行了一项元分析,以量化牙周炎和AMD之间的关联.
主要成果:
- 分析显示,牙周炎和AMD之间存在显著的关联.
- 在患有牙周炎的个体中,AMD的综合几率比为1.42 (95% CI:1.12至1.78;p = 0.003).
- 在包括的研究中,研究设计和两种疾病的诊断标准都存在异质性.
结论:
- 牙周炎与与年龄相关的黄斑变性 (AMD) 的风险增加有显著的关联.
- 与不可修改的AMD风险因素 (遗传学,年龄) 不同,牙周炎是一种可治疗的疾病.
- 管理牙健康,特别是治疗牙周炎,为个性化AMD风险降低策略提供了潜在的途径.
更多相关视频
相关概念视频
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
Pharmacodynamics in Geriatric Patients: Effects of Age
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...


